List of articles in "Drug" category - Page 361

Mapatumumab (HGS-ETR1) is an experimental human monoclonal antibody undergoing clinical trials for the treatment of cancer.This drug was discovered by Cambridge Antibody Technology (CAT) and Human Genome Sciences Inc. (HGS) […]

Lexatumumab (also known as ETR2-ST01) is an experimental agonistic human monoclonal antibody against TRAIL-R2 (DR5 APO-2) undergoing clinical trials for the treatment of cancer.HGS-ETR2 antibodies were generated by HGS through […]

Iratumumab is a human monoclonal antibody used in the treatment of oncological diseases such as relapsed refractory CD30-positive lymphoma including Hodgkin’s disease.This drug was developed by Medarex Inc.

Volociximab (also known as M200) is a chimeric monoclonal antibody jointly developed by PDL BioPharma and Biogen Idec for treatment of a variety of advanced solid tumors. It binds to […]

Pagibaximab is a chimeric monoclonal antibody for the prevention of staphylococcal sepsis in infants with low birth weight. As of March 2010 it is undergoing Phase II/III clinical trials.

Urtoxazumab is a humanized monoclonal antibody against diarrhoea caused by Escherichia coli serotype O121. The drug is designed to bind to a toxin of this bacterium so that it can […]

Nerelimomab is a mouse monoclonal antibody acting as a TNF inhibitor.

Epratuzumab (planned trade name LymphoCide) is a humanized monoclonal antibody. Potential uses may be found in oncology and in treatment of inflammatory autoimmune disorders such as systemic lupus erythematosus (SLE). […]

Menatetrenone (INN) also known as MK4 is a vitamin K compound used as a hemostatic agent and also as adjunctive therapy for the pain of osteoporosis. Menatetrenone is one of […]

Batroxobin is a serine protease derived from the venom of Bothrops atrox. Its molecular weight is approximately 43000 g/mol−1.This thrombin-like proteolytic enzyme splits the 16 Arg-17 Gly bond in the […]